Ozempic
Product Images NDC 50090-5139

Product Visual Gallery

This gallery contains 100 technical images submitted to the FDA as part of the official labeling for Ozempic (NDC 50090-5139). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Image 01)

Chemical structure diagram showing the molecular configuration of the active ingredient in Ozempic, including amino acid sequences and molecular side chains, as submitted by A-S Medication Solutions.*

FDA Label Image

Figure 1 (Image 02)

A line graph depicting plasma glucose (mg/dL) over 24 hours following a breakfast meal. The graph compares the effects of Ozempic at doses of 0.5 mg and 1 mg versus placebo, showing plasma glucose levels at baseline and after treatment.*

FDA Label Image

Figure 2 (Image 03)

A line graph depicting insulin secretion rate (pmol/kg/min) versus plasma glucose concentration (mg/dL). The graph compares baseline and end-of-treatment insulin secretion rates for CCFMIPF and placebo groups, as well as healthy subjects, across a glucose range from about 90 to 210 mg/dL.*

FDA Label Image

Figure 3 (Image 04)

A forest plot chart illustrating relative semaglutide exposure (Cavg) and 90% confidence intervals for different intrinsic factors including sex, age groups (65-74, >74 years), race (Black or African American, Asian), ethnicity (Hispanic or Latino), body weight (55 kg, 127 kg), and renal impairment severity (mild, moderate, severe). The chart compares exposure ratios relative to a reference profile defined as a non-Hispanic/non-Latino, White, female below 65 years, weighing 85 kg with normal renal function.*

FDA Label Image

Figure 4 (Image 05)

A chart showing the relative exposure ratio with 90% confidence intervals for various co-administered medications including Metformin, S-warfarin, R-warfarin, Digoxin, Atorvastatin, Ethinylestradiol, and Levonorgestrel. The graph indicates recommendations of no dose adjustment for each medication when co-administered.*

FDA Label Image

Figure 5 (Image 06)

A line graph comparing HbA1c percentage over weeks post randomization for Ozempic 0.5 mg, Ozempic 1 mg, and Sitagliptin treatments. The x-axis represents weeks post randomization up to week 56, and the y-axis shows HbA1c percentages from approximately 6.0 to 8.5. The graph includes data points at scheduled visits and indicates the number of patients in each treatment group at different time points, with error bars representing standard error at week 56.*

FDA Label Image

Warning 1 (Image 07)

Ozempic 1.34 mg/0.5 mL injectable solution cartridge carton by A-S Medication Solutions. The packaging label shows the brand name Ozempic prominently with dose strength 1.34 mg/0.5 mL, indicating it is a cartridge for a reusable injector pen. The label features a pink and purple geometric design.*

FDA Label Image

Device 1 (Image 08)

Illustration showing Ozempic pen and NovoFine Plus needle parts and features. Labels identify the pen cap, outer and inner needle caps, needle, paper tab, pen window, expiration date location, dose counter, dose pointer, dose selector, and dose button. Symbols for flow check and dashed line guide for dose setting are also shown.*

FDA Label Image

A (Image 09)

An instructional illustration showing a person holding a pen injector device, positioning the dosing knob with one hand while securing the body of the pen with the other hand, likely demonstrating how to prepare or use the Ozempic pen injector.*

FDA Label Image

B (Image 10)

An instructional illustration showing a hand holding a pen-like device, likely representing the administration or use of a medication delivery device such as an injection pen. The device is gripped by the fingers, suggesting preparation or use steps for the product Ozempic.*

FDA Label Image

Flow_symbol (Image 100)

Ozempic 2 mg/mL solution in a single-dose prefilled pen. The label shows the proprietary name Ozempic, strength 2 mg/mL, route subcutaneous, and instructions for storage. The labeler is A-S Medication Solutions. The pen contains 1.5 mL of solution with product NDC 50090-5139.*

FDA Label Image

Symbol (Image 101)

The image shows a white rectangular carton for Ozempic by A-S Medication Solutions. The front panel prominently displays the brand name "Ozempic" in large green letters. The bottom part of the carton has the text "injectable pen" indicating the dosage form. The label also includes a blue accent and contains additional small text not fully legible in the image.*

FDA Label Image

C (Image 11)

Illustration showing a close-up of a hand holding an injection pen. An arrow indicates the direction to press or engage the pen mechanism, likely demonstrating part of the injection process for the Ozempic pen.*

FDA Label Image

D (Image 12)

An instructional illustration showing a hand holding a medication pen, with a finger positioned near the injection button, demonstrating the step of preparing or administering an injection using the pen device.*

FDA Label Image

E (Image 13)

Instructional diagram showing a close-up of hands preparing a prefilled Ozempic injection pen by attaching a needle. The image illustrates the step of securing the needle before administration.*

FDA Label Image

F (Image 14)

An instructional illustration showing a step in the injection process. It depicts a hand holding a syringe or pen injector, aligning a needle or cap with the device, indicated by a directional arrow guiding the motion.*

FDA Label Image

Warning 2 (Image 15)

Ozempic subcutaneous solution 0.5 mg/0.5 mL in a 1.5 mL pen injector carton by A-S Medication Solutions. The packaging shows one pen injector with manufacturer and product name, including dosage strength and usage instructions visible on the back panel.*

FDA Label Image

Dose 1 (Image 16)

Packaging label for Ozempic, a medication by A-S Medication Solutions. The label shows the brand name Ozempic prominently but does not display active ingredients, strength, dosage form, or package size information.*

FDA Label Image

G (Image 17)

An instructional diagram illustrating the process of verifying the flow check symbol on an Ozempic pen device. The image shows hands holding the pen and the flow check indicator to ensure correct preparation or operation.*

FDA Label Image

H (Image 18)

An instructional illustration showing a hand holding an Ozempic injection pen by A-S Medication Solutions. The image depicts the proper grip and an arrow indicating an upward movement, likely demonstrating how to remove the pen cap or prepare the device for use.*

FDA Label Image

Warning 3 (Image 19)

Ozempic single-dose injection pen carton by A-S Medication Solutions. The packaging prominently displays the brand name Ozempic and depicts a pen device adjacent to a partially visible vial graphic against a predominantly purple background.*

FDA Label Image

Dash 1 (Image 20)

Ozempic 2 mg/1.5 mL solution in a pre-filled pen carton manufactured by A-S Medication Solutions. The packaging displays product branding, dosage strength, and includes the NDC 50090-5139. The carton has a colorful design with blue, purple, green, and white elements.*

FDA Label Image

I (Image 21)

An instructional illustration showing a close-up of a dosing device with the text 'Dashed line' indicating alignment and '1 mg selected' for dose selection. The image visually guides on setting a 1 mg dose on the device, likely related to Ozempic.*

FDA Label Image

Warning 4 (Image 22)

Ozempic 1.5 mg/mL injection pen carton by A-S Medication Solutions. The packaging features the Ozempic brand name prominently, dosage strength of 1.5 mg/mL, and highlights the ready-to-use prefilled pen with a dosage meter set at 0.25 mg. The design includes branding and essential product details visible on the front panel.*

FDA Label Image

J (Image 23)

An instructional illustration showing how to use a dose counter stopper on a pen device. It displays a close-up of a hand placing the stopper onto the pen, with an inset indicating the dose counter showing '1 mg left.' The image guides users on managing and tracking the remaining dose.*

FDA Label Image

K (Image 24)

An instructional diagram showing front and back views of a human torso, highlighting areas on the abdomen, thigh, and upper arm for medication injection sites. The image is likely intended to indicate appropriate locations for subcutaneous injection.*

FDA Label Image

L (Image 25)

An instructional illustration showing a hand holding a pen-like medical device with a downward arrow below it, indicating the action of pushing or pressing the device downward. The drawing is in a simple blue and white color scheme.*

FDA Label Image

M (Image 26)

An instructional diagram showing a hand holding an injection pen. The pen has a dial and a needle, and an arrow indicates the direction for administration. The illustration appears to guide the user on how to properly use the injection pen device.*

FDA Label Image

N (Image 27)

An instructional illustration showing a hand holding a pen-like device, with a speech bubble instructing to count slowly from 1 to 6. This likely demonstrates a step in using an injection or dosing device for the product Ozempic.*

FDA Label Image

O (Image 28)

An instructional illustration showing the injection pen tip of Ozempic with an arrow pointing upward, indicating a step in the preparation or administration process for the Ozempic injection pen.*

FDA Label Image

Warning 5 (Image 29)

Ozempic packaging label by A-S Medication Solutions, displaying the proprietary name prominently. The label is white with dark blue and pink design elements. No dosage strength, form, or package size is visible on the label in this image.*

FDA Label Image

P (Image 30)

Instructional illustration showing a hand preparing a cartridge or pen injector by turning or removing the cap in an upward direction, indicated by a blue arrow. The image likely guides the initial step of using a medication delivery device.*

FDA Label Image

Q (Image 31)

An instructional diagram showing a hand holding a cap above a container, with an arrow indicating the removal of the cap from the container's top. The image visually guides the user to open or remove the cap from the container.*

FDA Label Image

R (Image 32)

An instructional diagram showing how to use a pen-style injector. It depicts a hand holding the injector with the other hand twisting or preparing the dose, demonstrating the proper way to administer medication using the device associated with Ozempic.*

FDA Label Image

S (Image 33)

An instructional illustration showing a step in the process of assembling or using a pen-style injection device. It depicts a pen cap being removed or attached by pulling or pushing, indicated by arrows.*

FDA Label Image

Warning 6 (Image 34)

Ozempic 0.25 mg injectable solution single-dose pen packaging. The box and pen are shown in a red and white color scheme, with the proprietary name Ozempic prominently displayed. The labeler is A-S Medication Solutions. The product is a prefilled disposable pen for subcutaneous injection.*

FDA Label Image

Warning 7 (Image 35)

Ozempic 2 mg/mL injection carton by A-S Medication Solutions. The packaging shows the brand name Ozempic prominently, along with the 2 mg/mL strength and a depiction of a pen device used for subcutaneous injection. The carton contains important usage and manufacturer details on the side visible.*

FDA Label Image

Qr1 (Image 36)

FDA Label Image

Bull 1 (Image 37)

FDA Label Image

Warning 8 (Image 38)

The image shows the front of a pharmaceutical carton labeled Ozempic, a 2 mg/1.5 mL injectable solution in a single-dose pen. The labeler is A-S Medication Solutions. The carton indicates this product contains a 1.5 mL pen injector and is designed for subcutaneous use.*

FDA Label Image

Device 2 (Image 39)

An instructional diagram of the Ozempic pen and NovoFine Plus needle components. It details the pen cap, pen window, dose counter, dose pointer, dose selector, dose button, and expiration date placement on the pen label. Additionally, it shows the outer and inner needle caps, needle, and paper tab of the needle, as well as symbols for flow check and a dashed line used to guide dose measurement.*

FDA Label Image

A (Image 40)

Instructional illustration showing hands manipulating a pen-like device, apparently for preparing or using a medication pen by twisting or clicking a component. The image focuses on the device and the user interaction steps required for its operation.*

FDA Label Image

B (Image 41)

An illustration showing a hand holding a pen injector device, presumably for Ozempic. The focus is on the pen injector tip, with a number '3' in the upper left corner, suggesting part of an instructional sequence.*

FDA Label Image

C (Image 42)

An instructional illustration showing a hand preparing a prefilled pen needle. It depicts the removal of the outer needle shield by pulling it straight off, with arrows indicating the direction of removal.*

FDA Label Image

D (Image 43)

An instructional illustration showing a hand holding an injector pen, with the other hand about to press the injection button. The image demonstrates the step of administering an injection using a pen device, specifically depicting the action of pressing down to inject the medication.*

FDA Label Image

E (Image 44)

An instructional illustration showing a person holding a pen-type injector with one hand while preparing to use a small needle or pen needle with the other hand. The image suggests steps related to the injection or assembly process for a medication device, possibly for Ozempic.*

FDA Label Image

F (Image 45)

An instructional illustration showing the attachment of a needle to an Ozempic prefilled pen injection device. The image includes arrows indicating the rotation motion required to secure the needle. The illustration is likely part of usage instructions for the Ozempic injectable product from A-S Medication Solutions.*

FDA Label Image

Warning 9 (Image 46)

Ozempic 2 mg/mL injection pen packaging label by A-S Medication Solutions. The image shows a white and green carton box displaying the product name Ozempic prominently, with the concentration 2 mg/mL. The label also includes a visual of the pen injector device and a note indicating the pen contains six 0.25 mg doses for injection.*

FDA Label Image

Dose 2 (Image 47)

The image shows a bottle label for Ozempic by A-S Medication Solutions. The label includes the proprietary name Ozempic prominently, with a white and lavender color scheme. Additional text and graphics are present but not fully legible in the image. This is consistent with packaging for a pharmaceutical injection product.*

FDA Label Image

G (Image 48)

An instructional diagram showing two hands interacting with a device labeled with 'G' at the top. The illustration highlights the selection of the 'Flow check symbol' indicated on the device's display screen, with an arrow pointing to the symbol to confirm selection. This image is likely part of usage instructions for the Ozempic injection device by A-S Medication Solutions.*

FDA Label Image

H (Image 49)

Illustration showing a hand holding an Ozempic injection pen with an arrow pointing upward, demonstrating the step to remove the pen cap before use.*

FDA Label Image

Warning 10 (Image 50)

Ozempic carton from A-S Medication Solutions, displaying the proprietary name prominently. The front face shows the brand name "Ozempic" in large font, with subtle mountain graphic elements. No dosage strength or additional labeling details visible.*

FDA Label Image

Dash 2 (Image 51)

Box of Ozempic 1.34 mg injection, a glucagon-like peptide-1 (GLP-1) receptor agonist, by A-S Medication Solutions. The image shows the front panel of the package, highlighting the proprietary name Ozempic and strength 1.34 mg. The label includes dosage form as injection and a picture of the injection pen device.*

FDA Label Image

I (Image 52)

An instructional diagram showing a finger pressing the injection button on a pen device. It indicates a dashed line on the pen with dosage examples: 0.25 mg and 0.56 mg selected. The illustration is likely intended to demonstrate dosage selection or injection technique for the Ozempic pen.*

FDA Label Image

Warning 11 (Image 53)

Packaging label for Ozempic by A-S Medication Solutions. The label includes the proprietary name Ozempic prominently displayed, with additional detail indicating it is a disposable injection device. The design features a blue and white color scheme with orange accent lines.*

FDA Label Image

J (Image 54)

An instructional illustration showing the uncapping of an Ozempic prefilled pen injector. The image demonstrates how to remove the dose counter stopper, indicating a dose of 0.25 mg per injection.*

FDA Label Image

K (Image 55)

An anatomical illustration showing front and back views of a human torso, highlighting the abdominal and thigh areas to indicate common injection sites for a medication. The image depicts the injection areas on the stomach and outer thighs.*

FDA Label Image

L (Image 56)

An illustration showing a person holding a pen injector device with one hand while positioning it at their abdomen. The image includes a downward arrow indicating the direction to inject the device into the skin.*

FDA Label Image

M (Image 57)

An instructional diagram illustrating the proper technique for administering an injection using a pen device. The image shows a hand holding the pen and pressing the injection button, highlighting the step-by-step injection process likely related to Ozempic.*

FDA Label Image

N (Image 58)

An instructional illustration showing a hand holding a syringe with a plunger being pushed slowly. A speech bubble from the hand reads 'Count slowly: 1-2-3-4-5-6,' indicating the step to inject slowly over the count of six seconds.*

FDA Label Image

O (Image 59)

An instructional illustration showing the step of pulling a blue cap off a pen injector device, indicated by a blue upward arrow. The image focuses on the top portion of the pen, likely demonstrating preparation for use.*

FDA Label Image

Warning 12 (Image 60)

Ozempic 1.34 mg/1.5 mL injectable solution pen box from A-S Medication Solutions. The carton contains one multidose pen of overdose strength 1.34 mg per 1.5 mL, intended for subcutaneous injection. The packaging highlights key usage instructions and dosage information on its front and side panels.*

FDA Label Image

P (Image 61)

An instructional illustration showing a close-up of a hand holding a pen-like device with a cap. An arrow indicates the cap is being twisted off or removed from the device, suggesting a step in the preparation or use of Ozempic injection pen.*

FDA Label Image

Q (Image 62)

An instructional diagram showing a drop falling from a small container onto the center of a round object with a cross-shaped slot, indicating an application or insertion step.*

FDA Label Image

R (Image 63)

An instructional illustration showing a person preparing an injection pen by removing the cap. The image highlights the steps involved in readying the pen device for use, commonly seen in medication administration guides for injectable drugs like Ozempic.*

FDA Label Image

S (Image 64)

An instructional diagram showing the connection process of two components, with arrows indicating the direction in which a cap or nozzle should be attached onto or detached from a cylindrical device. The image likely illustrates assembly or usage steps for a medical device or product component.*

FDA Label Image

Warning 13 (Image 65)

Packaging label for Ozempic by A-S Medication Solutions. The label includes the proprietary name Ozempic prominently displayed with graphic elements in green and white. No specific strength, dosage form, or package count is visible in the image.*

FDA Label Image

Warning 14 (Image 66)

Ozempic 1 mg/0.5 mL solution for injection in a single-dose pen cartridge by A-S Medication Solutions. The packaging features the product name, strength, dosage form, a 2.85 mL cartridge volume, and a 1x dose indication with a purple and white color scheme.*

FDA Label Image

Qr2 (Image 67)

FDA Label Image

Bull 2 (Image 68)

FDA Label Image

Figure 6 (Image 71)

A Kaplan-Meier curve chart comparing the percentage of patients with an event over time in weeks between Ozempic and placebo groups. The graph shows Ozempic with a lower event rate trend compared to placebo. Below are numbers of patients at risk at various time points for each group. The chart includes a hazard ratio (HR) value with confidence interval.*

FDA Label Image

Warningtriangle (Image 72)

Ozempic drug packaging label from A-S Medication Solutions showing the proprietary name "Ozempic" and product NDC 50090-5139. The label features a white background with text and a distinctive orange and pink geometric design in the center, without visible dosage form or strength details.*

FDA Label Image

Overview (Image 73)

Illustration diagram of the Ozempic pen and NovoFine Plus needle, showing labeled parts including pen cap, pen window, dose counter, dose pointer, dose selector, dose button, outer and inner needle caps, needle, and paper tab. Also highlights flow check symbol and dashed line guide on the dose selector.*

FDA Label Image

Fig. A (Image 74)

An instructional diagram showing a person's hands removing the cap from a pen injector device by pulling it straight off. The image is a step in the usage process for the Ozempic injectable medication pen supplied by A-S Medication Solutions.*

FDA Label Image

Fig. B (Image 75)

An instructional illustration showing a hand holding a blue-capped pen-like device with a gray detachable tip on the right end. The image is labeled with the letter "B" in a blue box in the upper left corner, indicating a step in a usage or assembly process.*

FDA Label Image

Fig. C (Image 76)

An instructional illustration showing two hands removing a cap from a pen injector by pulling the cap straight off, indicated by an arrow pointing away from the pen. The image is labeled with a letter 'C' in the top left corner.*

FDA Label Image

Fig. D (Image 77)

An instructional illustration showing a close-up of a hand twisting or turning the tip of a prefilled injection pen device, with an arrow indicating the direction of rotation. The device is likely related to administration instructions for Ozempic, a medication pen.*

FDA Label Image

Fig. E (Image 78)

An instructional illustration showing a hand removing the protective cap from the needle of a pen injector device. The image uses an arrow to indicate the direction of cap removal, demonstrating the first step in preparing the Ozempic pen injector for use.*

FDA Label Image

Fig. F (Image 79)

An instructional illustration showing a person removing a protective cap from the tip of an Ozempic injection pen. The image highlights the hand's position and the removal motion indicated by a directional arrow.*

FDA Label Image

Warningtriangle (Image 80)

Ozempic 1.34 mg per 0.5 mL injectable solution in a pre-filled pen. The label shows the product name, strength, dosage form, manufacturer A-S Medication Solutions, and includes storage and dosage instructions. The NDC 50090-5139 is visible on the label.*

FDA Label Image

Fig. G (Image 81)

Instructional illustration showing two hands holding an Ozempic pen injector. It depicts twisting the bottom part of the pen to select the flow check symbol, which is highlighted to confirm proper function before use.*

FDA Label Image

Fig. H (Image 82)

An instructional diagram showing a hand holding the Ozempic pen injector with a close-up view of the pen's dial and button mechanism. The illustration includes an upward arrow indicating a step to pull or adjust the pen cap or dial, likely part of the preparation or use instructions for the injection device.*

FDA Label Image

Warningtriangle (Image 83)

Ozempic injection pen packaging label showing the product name Ozempic. The label includes the A-S Medication Solutions logo and indicates the device is an injection pen. The label features a purple color scheme and icons suggesting injection use, with dosage instructions references in the design.*

FDA Label Image

Fig. I (Image 84)

Instructional illustration showing how to read the dose window on an Ozempic injection pen. It highlights the dashed dose line and indicates the selection of a 1 mg dose.*

FDA Label Image

Warningtriangle (Image 85)

Ozempic 1 mg/mL injection pen packaging label by A-S Medication Solutions. The label shows a multi-dose injectable pen cartridge with product name, strength, and manufacturer. The label also displays regulatory and handling information on a white and orange background with black and red text.*

FDA Label Image

Fig. J (Image 86)

Illustration showing a close-up of a dose counter on an Ozempic injection pen by A-S Medication Solutions. It details the dose counter stopped at 1 mg left and includes a hand turning a dial or cap to adjust or confirm the dosage.*

FDA Label Image

Fig. K (Image 87)

An instructional illustration showing areas of the human body — the abdomen and the front and back of the thighs — highlighted as recommended injection sites for subcutaneous administration. The image is intended for guidance on proper injection locations.*

FDA Label Image

Fig. L (Image 88)

Instructional illustration showing a hand holding an Ozempic injection pen vertically with the needle pointing downward, indicating the orientation for proper injection technique.*

FDA Label Image

Fig. M (Image 89)

An instructional illustration showing a hand holding an Ozempic injection pen pressed against a forearm, with an arrow indicating downward movement to administer the injection. A close-up inset displays the dose window set to "0 mg". The image guides injection technique for Ozempic by A-S Medication Solutions.*

FDA Label Image

Fig. N (Image 90)

An illustration showing a hand holding a pen-like injector device against the forearm. A speech bubble instructs to count slowly from 1 to 6 while performing the injection, indicating a step in the usage process. This likely relates to Ozempic, an injectable medication by A-S Medication Solutions.*

FDA Label Image

Fig. O (Image 91)

Instructional illustration showing a close-up of the tip of a pen injector with an upward arrow beside it, indicating removal or attachment of a cap or needle component.*

FDA Label Image

Warningtriangle (Image 92)

Ozempic injection pen packaging label showing the brand name Ozempic. The label includes the manufacturer's name, A-S Medication Solutions, along with information about the contents and usage. The label features a yellow and green color scheme with dosage and other instruction details.*

FDA Label Image

Fig. P (Image 93)

An instructional illustration showing a hand twisting the cap off a pen-style injector. The image focuses on the initial step of preparing the device for use, indicated by an arrow pointing counterclockwise to remove the cap.*

FDA Label Image

Fig. Q (Image 94)

An instructional illustration showing a medication vial with a rubber stopper being punctured by a needle. A blue arrow indicates the needle insertion point on the vial's top surface, guiding proper injection technique for drawing medication.*

FDA Label Image

Fig. R (Image 95)

An instructional illustration showing two hands holding a pen-like device with a blue arrow indicating to twist or pull the cap from the device, likely demonstrating part of the usage or preparation steps for Ozempic by A-S Medication Solutions.*

FDA Label Image

Fig. S (Image 96)

An instructional illustration showing the attachment of a needle cap to the Ozempic injection pen. The image features arrows indicating the direction to attach or secure the needle to the pen, depicted on a light blue background.*

FDA Label Image

Warningtriangle (Image 97)

Ozempic packaging label from A-S Medication Solutions, displaying the proprietary name prominently in large font. The label features branding colors with a purple and yellow background and a stylized white letter 'O'. No additional product details such as strength, dosage form, or package size are visible in the image.*

FDA Label Image

Warningtriangle (Image 98)

Ozempic box packaging by A-S Medication Solutions. The carton is teal and white with orange accents featuring the Ozempic brand name prominently on the front. It is a medication product box, although specific strength, dosage form, or quantity details are not visible in the image.*

FDA Label Image

Picture (Image 99)

FDA Label Image

Label Image (Lbl500905139)

Ozempic (semaglutide) injection prefilled pen label by A-S Medication Solutions. The label indicates 2 mg/1.5 mL (1.34 mg/mL) strength per pen, containing 6 mg of semaglutide in 2.0 mL. Storage instructions specify refrigerating without freezing, and the product includes NovoFine Plus 32G needles and literature. NDC 50090-5139.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.